OBJECTIVE: To determine the distribution of the age at onset of diabetes (maturity-onset diabetes of the young-3 [MODY3]) and to identify determinants of the onset of diabetes in carriers of HNF-1alpha mutations. RESEARCH DESIGN AND METHODS: Extended families (n = 104) with type 2 diabetes inherited in a dominant pattern were recruited and screened for diabetes-causing mutations in HNF-1alpha. RESULTS: HNF-1alpha mutations cosegregated with diabetes in only 13 families, all with a mean age at onset <35 years. Insulin secretion was diminished or absent in mutation carriers (n = 101), and diabetes developed in 65% by age 25 years and in 100% by age 50 years. If the mutation was inherited from the mother, diabetes onset was very young in those exposed to diabetes in utero; 57 +/- 8% were affected by age 15 years as compared with 0.0% in those not exposed (P < 7 x 10(-6)). By age 25 years, the difference was reduced (85 +/- 6 and 55 +/- 12%, respectively; P = 0.02). If the mutation was inherited from the father, diabetes developed in 52 +/- 8% by age 25 years. Age at diagnosis was shown to be highly heritable (h(2) = 0.47, P = 0.003). When parent of origin was included in the analyses, the magnitude of genetic contribution increased markedly (h(2) = 0.91). CONCLUSIONS: Mutations in HNF-1alpha accounts for diabetes in a small proportion of families with a dominant pattern of inheritance. Age at onset of diabetes in MODY3 families varied widely and was influenced by familial factors (including modifying genes) and parent of origin (whether a mutation carrier was exposed to diabetes in utero).
OBJECTIVE: To determine the distribution of the age at onset of diabetes (maturity-onset diabetes of the young-3 [MODY3]) and to identify determinants of the onset of diabetes in carriers of HNF-1alpha mutations. RESEARCH DESIGN AND METHODS: Extended families (n = 104) with type 2 diabetes inherited in a dominant pattern were recruited and screened for diabetes-causing mutations in HNF-1alpha. RESULTS:HNF-1alpha mutations cosegregated with diabetes in only 13 families, all with a mean age at onset <35 years. Insulin secretion was diminished or absent in mutation carriers (n = 101), and diabetes developed in 65% by age 25 years and in 100% by age 50 years. If the mutation was inherited from the mother, diabetes onset was very young in those exposed to diabetes in utero; 57 +/- 8% were affected by age 15 years as compared with 0.0% in those not exposed (P < 7 x 10(-6)). By age 25 years, the difference was reduced (85 +/- 6 and 55 +/- 12%, respectively; P = 0.02). If the mutation was inherited from the father, diabetes developed in 52 +/- 8% by age 25 years. Age at diagnosis was shown to be highly heritable (h(2) = 0.47, P = 0.003). When parent of origin was included in the analyses, the magnitude of genetic contribution increased markedly (h(2) = 0.91). CONCLUSIONS: Mutations in HNF-1alpha accounts for diabetes in a small proportion of families with a dominant pattern of inheritance. Age at onset of diabetes in MODY3 families varied widely and was influenced by familial factors (including modifying genes) and parent of origin (whether a mutation carrier was exposed to diabetes in utero).
Authors: Maciej Borowiec; Chong W Liew; Ryan Thompson; Watip Boonyasrisawat; Jiang Hu; Wojciech M Mlynarski; Ilham El Khattabi; Sung-Hoon Kim; Lorella Marselli; Stephen S Rich; Andrzej S Krolewski; Susan Bonner-Weir; Arun Sharma; Michele Sale; Josyf C Mychaleckyj; Rohit N Kulkarni; Alessandro Doria Journal: Proc Natl Acad Sci U S A Date: 2009-08-10 Impact factor: 11.205
Authors: B Liljeström; K Aktan-Collan; B Isomaa; L Sarelin; A Uutela; L Groop; H Kääriäinen; T Tuomi Journal: Diabetologia Date: 2005-01-20 Impact factor: 10.122
Authors: Marcus G Pezzolesi; Jackson Jeong; Adam M Smiles; Jan Skupien; Josyf C Mychaleckyj; Stephen S Rich; James H Warram; Andrzej S Krolewski Journal: PLoS One Date: 2013-03-29 Impact factor: 3.240
Authors: Hana Lango Allen; Stefan Johansson; Sian Ellard; Beverley Shields; Jens K Hertel; Helge Raeder; Kevin Colclough; Anders Molven; Timothy M Frayling; Pål R Njølstad; Andrew T Hattersley; Michael N Weedon Journal: Diabetes Date: 2009-09-30 Impact factor: 9.461